Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
1.91M
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$64.7M
-
Value change
-
+$1.32M
-
Number of buys
-
16
-
Number of sells
-
-14
-
Price
-
$33.86
Significant Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q1 2021
33 filings reported holding IMNM - Immunome Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.91M shares
of 111M outstanding shares and own 1.72% of the company stock.
Largest 10 shareholders include Alpine Global Management, LLC (796K shares), Prentice Capital Management, LP (332K shares), FMR LLC (226K shares), VANGUARD GROUP INC (154K shares), BlackRock Inc. (113K shares), Cerity Partners LLC (110K shares), GEODE CAPITAL MANAGEMENT, LLC (49.3K shares), STATE STREET CORP (32.6K shares), NORTHERN TRUST CORP (27.1K shares), and Baldwin Investment Management, LLC (25.4K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.